Cargando…
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits the penetration of therapeutic molecules to the brain after oral or parenteral administration, which, in combination wit...
Autores principales: | Lee, David, Minko, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704573/ https://www.ncbi.nlm.nih.gov/pubmed/34959331 http://dx.doi.org/10.3390/pharmaceutics13122049 |
Ejemplares similares
-
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021) -
Neurogenic Hypertension, the Blood–Brain Barrier, and the Potential Role of Targeted Nanotherapeutics
por: Lamptey, Richard Nii Lante, et al.
Publicado: (2023) -
DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER
por: Kiguchi, Hiro, et al.
Publicado: (2020) -
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus
por: Majumder, Joydeb, et al.
Publicado: (2020) -
Bypassing the Blood–Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies
por: Gernert, Manuela, et al.
Publicado: (2020)